BioSpace News Archive

Sanara MedTech Inc. announced the first sale of ALLOCYTE® Plus Advanced Viable Bone Matrix.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its Maestro Microcatheter product line to now include a new longer length for radial embolization procedures.

Alcami Corporation, a leading contract development and manufacturing organization, announced the appointment of Tariq Jamal to Chief Information Officer.

SOHM has entered into development collaboration with the University of Arizona Center for Innovation to propel ABBIE, a non-viral gene-editing kit technology.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Bradley Monk, MD will join the statewide practice as Medical Director of Late-Phase Research, effective January 1, 2024.

Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”) today announced the award of the first Canadian patent for its revolutionary UltraShearTM Technology (UltraShearTM or USTTM) platform.

ADM (NYSE: ADM) will release financial results for the third quarter of 2023 before the market opens on Tuesday, Oct. 24, 2023.

As the AstraZeneca Foundation celebrates its 30th anniversary, the organization has awarded 12 nonprofit organizations $2,170,318 in grants across eight US states and Washington, D.C., for innovative approaches to address healthcare disparities at the community level, a reflection of AstraZeneca’s broader commitment to advance health equity efforts.

Oryzon Genomics, S.A. announced today that the company presented an update on vafidemstat’s ongoing Phase IIb PORTICO trial in borderline personality disorder (BPD) at the 36th European College held on October 7-10 in Barcelona, Spain.

Cybrexa Therapeutics today announced it will present data findings on its preclinical candidate, CBX-15 (alphalex™-MMAE) for the treatment of triple negative breast cancer in a poster session at the 35th AACR-NCI-EORTC (ANE) Symposium.